ABBV | AbbVie Inc. Stock Overview

(Stock Exchange: NYSE)

Day's Range	200.02 - 203.97
52 Week Range	153.58 - 207.32
Beta	0.61
Implied Volatility	22.17%
IV Rank	32.62%
Day's Volume	3,802,111
Average Volume	5,975,815
Shares Outstanding	1,765,350,000
Market Cap	356,741,928,000
Sector	Healthcare
Industry	Drug Manufacturers - General
IPO Date	2013-01-02

Valuation
Profitability
Growth
Health
P/E Ratio	84.55
Forward P/E Ratio	15.36
EPS	2.39
1YR Price Target	175.00
Dividend Yield	3.27%
Dividend Per Share	4.28
Dividend ExDate	2024-01-12
Dividend PayDate	2024-02-15
Employees	50,000
Country	USA
Website	ABBV

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. The company's primary product is Humira, administered via injection.

ABBV's peers: MRK, PFE, LLY, BMY, JNJ, AMGN, GILD, ABT, AMRN, AZN, BIIB, GSK, NVS, OGN, SNY, SCLX

*Chart delayed

Analyzing fundamentals for ABBV we got that it has average fundamentals where Valuation is considered to be fairly valued, Profitability is moderate, Growth is exceptionally good and Health is very weak. For more detailed analysis please see ABBV Fundamentals page.

Watching at ABBV technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on ABBV Technicals page.